Schizophrenia Drugs Market Value

Companies Increase Focus on Second-generation Drugs with Polypharmacology Approach Several doctors and healthcare providers are adopting the methods of polypharmacology to develop new drugs for mental disorders. These methods are providing better outcomes in patients as compared to single-target drugs in the schizophrenia drugs market. Likewise, multi-target drugs are emerging as an effective alternative to […]